PE20142306A1 - Amidas de compuestos de 2-amino-4-ariltiazol y sus sales - Google Patents

Amidas de compuestos de 2-amino-4-ariltiazol y sus sales

Info

Publication number
PE20142306A1
PE20142306A1 PE2014002226A PE2014002226A PE20142306A1 PE 20142306 A1 PE20142306 A1 PE 20142306A1 PE 2014002226 A PE2014002226 A PE 2014002226A PE 2014002226 A PE2014002226 A PE 2014002226A PE 20142306 A1 PE20142306 A1 PE 20142306A1
Authority
PE
Peru
Prior art keywords
aryltiazole
amino
compounds
amidas
salts
Prior art date
Application number
PE2014002226A
Other languages
English (en)
Spanish (es)
Inventor
Suresh Mahadev Kadam
Abraham Thomas
Sukumar Sinha
Sukeerthi Kumar
Bipin Parsottam Kansagra
Sachin Gavhane
Sandeep Khandagale
Jayant Prakashrao Patil
Shailendra Bhadane
Bhavna Mishra
Rajesh Dwivedi
Shailesh Pawase
Original Assignee
Glenmark Pharmaceuticals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54193746&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20142306(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glenmark Pharmaceuticals Sa filed Critical Glenmark Pharmaceuticals Sa
Publication of PE20142306A1 publication Critical patent/PE20142306A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
PE2014002226A 2012-06-08 2013-06-08 Amidas de compuestos de 2-amino-4-ariltiazol y sus sales PE20142306A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN1687MU2012 2012-06-08
US201261665282P 2012-06-27 2012-06-27
IN3519MU2012 2012-12-13
US201261748016P 2012-12-31 2012-12-31

Publications (1)

Publication Number Publication Date
PE20142306A1 true PE20142306A1 (es) 2015-01-16

Family

ID=54193746

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2014002226A PE20142306A1 (es) 2012-06-08 2013-06-08 Amidas de compuestos de 2-amino-4-ariltiazol y sus sales

Country Status (22)

Country Link
US (1) US9458173B2 (OSRAM)
EP (1) EP2858999B1 (OSRAM)
JP (1) JP5989900B2 (OSRAM)
KR (1) KR20150015488A (OSRAM)
CN (1) CN104350058A (OSRAM)
AP (1) AP3546A (OSRAM)
AU (1) AU2013273118B2 (OSRAM)
BR (1) BR112014029155A2 (OSRAM)
CA (1) CA2873570C (OSRAM)
CL (1) CL2014003317A1 (OSRAM)
EA (1) EA031334B1 (OSRAM)
HK (1) HK1207643A1 (OSRAM)
IL (1) IL236084A0 (OSRAM)
IN (1) IN2014MN02467A (OSRAM)
MX (1) MX354014B (OSRAM)
MY (1) MY165622A (OSRAM)
NZ (1) NZ701721A (OSRAM)
PE (1) PE20142306A1 (OSRAM)
PH (1) PH12014502685B1 (OSRAM)
SG (1) SG11201408093PA (OSRAM)
WO (1) WO2013183035A2 (OSRAM)
ZA (1) ZA201500082B (OSRAM)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2875692A1 (en) 2012-06-08 2013-12-12 Selcia Limited Macrocyclic inhibitors of flaviviridae viruses
AR091279A1 (es) 2012-06-08 2015-01-21 Gilead Sciences Inc Inhibidores macrociclicos de virus flaviviridae
JP2016522251A (ja) 2013-06-20 2016-07-28 グレンマーク ファーマシューティカルズ, エセ.アー. Trpa1アンタゴニストを含むナノ粒子製剤
WO2016023832A1 (en) * 2014-08-11 2016-02-18 Hydra Biosciences, Inc. Thieno- and furo[2,3-d]pyrimidine-2,4[1h,3h]-dione derivatives as trpc5 modulators for the treatment of neuropsychiatric disorders
US20190175599A1 (en) * 2014-09-16 2019-06-13 Glemark Pharmaceuticals S.A. Trpa1 antagonist for the treatment of pain associated to diabetic neuropathic pain
TW202321229A (zh) 2021-08-18 2023-06-01 美商富曼西公司 殺真菌的取代的雜環化合物
CN114671875A (zh) * 2022-04-27 2022-06-28 成都施贝康生物医药科技有限公司 新型二氢嘧啶类化合物、异构体或盐及其制备方法和用途

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2248231A1 (de) 1972-10-02 1974-04-11 Basf Ag 3-aminoisothiazolo eckige klammer auf 3,4-d eckige klammer zu pyrimidine
SE9701398D0 (sv) 1997-04-15 1997-04-15 Astra Pharma Prod Novel compounds
ES2193839B1 (es) 2001-06-22 2005-02-16 Almirall Prodesfarma, S.A. Nuevos derivados de 6-fenildihidropirrolpirimidindiona.
WO2004014916A1 (en) 2002-08-13 2004-02-19 Warner-Lambert Company Llc Pyrimidine fused bicyclic metalloproteinase inhibitors
US6890923B2 (en) 2002-12-16 2005-05-10 Astrazeneca Ab Compounds
AU2003290066A1 (en) 2002-12-18 2004-07-09 Novartis Ag Anktm1, a cold-activated trp-like channel expressed in nociceptive neurons
WO2005019188A1 (ja) 2003-08-22 2005-03-03 Takeda Pharmaceutical Company Limited 縮合ピリミジン誘導体およびその用途
US20070099940A1 (en) 2004-02-11 2007-05-03 Spearing Paul K Pth agonists
US20070196866A1 (en) 2004-03-13 2007-08-23 Irm Llc Modulators of ion channel trpa1
JPWO2006083005A1 (ja) 2005-02-03 2008-06-26 武田薬品工業株式会社 縮合ピリミジン誘導体およびその用途
JP2009503107A (ja) 2005-08-04 2009-01-29 アポジー・バイオテクノロジー・コーポレイション スフィンゴシンキナーゼ阻害剤およびそれらの使用方法
US20070105920A1 (en) 2005-11-08 2007-05-10 Akzo Nobel N.V. 2-(Benzimidazol-1-Yl)-N-(4-phenylthiazol-2-yl) acetamide derivatives
TWI610684B (zh) * 2005-12-22 2018-01-11 海卓勒生物科學公司 用於調節trpa1功能之化合物
CN101454318A (zh) * 2006-03-22 2009-06-10 阿斯利康(瑞典)有限公司 吡啶并嘧啶衍生物及其作为pde4抑制剂的用途
TW200800997A (en) 2006-03-22 2008-01-01 Astrazeneca Ab Chemical compounds
JP2011201776A (ja) 2008-07-23 2011-10-13 Mochida Pharmaceut Co Ltd ヘテロシクリデン−n−(3,4−ジヒドロ−2(1h)−キナゾリノン−5−イル)アセトアミド誘導体
AR065081A1 (es) 2007-01-29 2009-05-13 Xenon Pharmaceuticals Inc Compuestos de quinazolinona y pirimidona fusionados y composicion farmaceutica
DK2170309T3 (en) 2007-06-22 2017-01-09 Hydra Biosciences Inc Dioxo-2,6, -2,3-dihydro-1H-purine compounds useful in the treatment of diseases related to activity of TRPA1 channel
WO2010004390A1 (en) * 2008-06-17 2010-01-14 Glenmark Pharmaceuticals, S.A. Quinazoline dione derivatives as trpa1 modulators
WO2009158719A2 (en) 2008-06-27 2009-12-30 Hydra Biosciences, Inc. Methods and compositions for treating disorders
CN102361874A (zh) * 2009-03-23 2012-02-22 格兰马克药品股份有限公司 作为trpa1调节剂的呋喃并嘧啶二酮衍生物
US8623880B2 (en) 2009-03-23 2014-01-07 Glenmark Pharmaceuticals S.A. Fused pyrimidine-dione derivatives as TRPA1 modulators
PT2411397E (pt) 2009-03-23 2013-06-06 Glenmark Pharmaceuticals Sa Derivados de isotiazolo-pirimidinadiona como moduladores de trpa1
MX2011009824A (es) 2009-03-23 2012-01-25 Glenmark Pharmaceuticals Sa Derivados de pirimidina-diona fusionados como moduladores del trpa1.
EA023141B1 (ru) 2010-12-20 2016-04-29 Гленмарк Фармасьютикалс С.А. Соединения 2-амино-4-арилтиазола в качестве антагонистов trpa1

Also Published As

Publication number Publication date
CL2014003317A1 (es) 2015-02-13
AP3546A (en) 2016-01-14
IL236084A0 (en) 2015-02-01
PH12014502685A1 (en) 2015-01-26
JP5989900B2 (ja) 2016-09-07
PH12014502685B1 (en) 2015-01-26
US20150111038A1 (en) 2015-04-23
MX2014014482A (es) 2015-06-05
EA031334B1 (ru) 2018-12-28
AU2013273118B2 (en) 2015-11-05
CN104350058A (zh) 2015-02-11
EA201492054A1 (ru) 2016-08-31
NZ701721A (en) 2016-03-31
BR112014029155A2 (pt) 2017-06-27
MY165622A (en) 2018-04-18
MX354014B (es) 2018-02-08
ZA201500082B (en) 2015-12-23
HK1207643A1 (en) 2016-02-05
US9458173B2 (en) 2016-10-04
EP2858999A2 (en) 2015-04-15
EP2858999B1 (en) 2017-05-10
SG11201408093PA (en) 2015-01-29
WO2013183035A2 (en) 2013-12-12
IN2014MN02467A (OSRAM) 2015-07-10
KR20150015488A (ko) 2015-02-10
WO2013183035A3 (en) 2014-02-27
JP2015520183A (ja) 2015-07-16
AP2014008076A0 (en) 2014-11-30
CA2873570C (en) 2016-11-01
CA2873570A1 (en) 2013-12-12
AU2013273118A1 (en) 2014-11-27

Similar Documents

Publication Publication Date Title
PE20142306A1 (es) Amidas de compuestos de 2-amino-4-ariltiazol y sus sales
NI201300103A (es) INHIBIDORES DE QUINASA RELACIONADOS CON PIRROLO [ 2, 3-d] PIRIMIDINA TROPOMIOSINA
IL228968A0 (en) Kinase inhibitors pyrazolo [4,3-d]pyrimidine compounds,compositions comprising the same and uses thereof
EP2897615A4 (en) PHARMACOKINETIC FORMULATIONS OF DEUTERATED BENZOCHINOL INHIBITORS OF THE VESICLE MONOAMINE TRANSPORTER 2
CU20140110A7 (es) Compuestos heterocíclicos como inhibidores de mek
EA201390199A1 (ru) 2-замещенные-8-алкил-7-оксо-7,8-дигидропиридо[2,3-d]пиримидин-6-карбонитрилы и их применение
AR083797A1 (es) Succinato de dimetil-amida del acido 7-ciclopentil-2-(5-piperazin-1-il-piridin-2-il-amino)-7h-pirrolo-[2,3-d]pirimidin-6-carboxilico, proceso para prepararla, intermediarios de dicha sintesis y proceso de preparacion de los mismos
UY33985A (es) Sales de 2,3-dihidroimidazo [1,2-c] quinazolina sustituida
FR2998297B1 (fr) Procede de preparation de sel d'imides contenant un groupement fluorosulfonyle
MX391445B (es) Formas cristalinas de 3-(imidazol[1,2-b] piridazin-3- iletinil)-4-metil-n-(4-[(4-metilpiperazin-1-il)metil]-3-(trifluorometil)fenil) benzamida y su sal de monoclorhidrato.
PT2820000T (pt) Sais besilato e tosilato de um derivado de dihidroquinazolina e sua utilização como agentes antivirais
MX2015014081A (es) Derivados de pirrolo[2,3-d]pirimidina como agonistas del receptor de canabinoides 2 (cb2).
FR2991323B1 (fr) Sel d'anions bicycliques aromatiques pour batteries li-ion
CR20140345A (es) Nuevas formas y sales de un dihidropirrolo [1,2-c] imidazolilo, inhibidor de la aldosterona sintasa o aromatasa
UY35236A (es) Compuestos de [1,2,4]triazol e imidazol sustituidos
ZA201400474B (en) A crystalline form of the sodium salt of 4-tert-butyl-n-[chloro-2-(1-oxy-pyridine-4-carbonyl)phenyl]-benzene sulfonamide
CO6821957A2 (es) Formas solidas y sales de los derivados de tetrahidro-pirido-pirimidinas
FR2991324B1 (fr) Sel d'anions bicycliques aromatiques pour batteries li-ion
EP2698371A4 (en) NEW VERBUNDADDITIONSALZ AGAINST THROMBOCYTES
SG10201602846TA (en) 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidine derivatives, their manufacture and use as antiviral agents
BR112014007850A2 (pt) métodos para a preparação de 5-[2-[7-(trifluormetil)-5-[4-(trifluormetil)fenil]pirazol[1,5-a]pirimidin-3-il]etinil]-2-piridinamina
PT2855422T (pt) Síntese de gelantes diamido através da utilização de sais dane de aminoácidos
ITRM20100144U1 (it) Impianto mobile di produzione energetica per l'alimentazione di utenze militari campali
ES1074675Y (es) Accesorio portabebes para bano y ducha
TH90536B (th) สารประกอบยูราซิล และสารฆ่าวัชพืช ซึ่งประกอบรวมด้วยสารเดียวกันนี้

Legal Events

Date Code Title Description
FD Application declared void or lapsed